Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-07
2006-03-07
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S282000, C514S538000
Reexamination Certificate
active
07008939
ABSTRACT:
A pharmaceutical composition for the treatment of an increased urge to urinate or urinary incontinence, comprising an effective amount of at least a compound selected from the group consisting of codeine, dihydrocodeine, dextropropoxyphene, meptazinol and tilidine. Also disclosed are methods of treatment using the pharmaceutical compositions and preferred dosages for the treatment methods.
REFERENCES:
patent: 5354863 (1994-10-01), Dappen et al.
patent: 5840696 (1998-11-01), Lippton
patent: 5859043 (1999-01-01), Kapusta
patent: RE36547 (2000-02-01), Crain et al.
patent: 6159501 (2000-12-01), Skinhoj
patent: 2003/0166670 (2003-09-01), Brooks-Korn
patent: 19947747 (2001-04-01), None
patent: 0913152 (1999-05-01), None
patent: WO 93/15062 (1993-08-01), None
patent: WO 98/46216 (1998-10-01), None
patent: WO 99/22737 (1999-05-01), None
Dray et al., “Meptazinol: Unusual In Vivo Opioid Receptor Activity at Supraspinal and Spinal Sites”,Neuropharmacology, vol. 25, No. 4 (1986), pp. 343-349.
JP 07053534 A, Patent Abstracts of Japan, no date available.
Parfitt, Martindale—The Complete Drug Reference—Thirty-Second Edition, Pharmaceutical Press, 1999, pp. 26-29, 34, 52-53, and 89.
Murray, “Acute Urinary Retention Associated with Sublingual Buprenorphine”,British Medical Journal, vol. 286, No. 6367 (1983), pp. 763-764.
Malinovsky et al., “The Urodynamic Effects of Intravenous Opioids and Ketoprofen in Humans”,Anesthesia and Analgesia, vol. 87, No. 2 (1998), pp. 456-461.
Fowler et al., “Effects of Liquid Diphenoxylate Hydrochloride and Atropine Sulfate (Lomotil) Instillations on Dynamics and Function of Continent Cecal Urinary Reservoirs”,The Journal of Urology, vol. 138, No. 4 (1987), pp. 735-738.
Aceto et al., “Stereoselective Mu- and Delta-Opioid Receptor-Related Antinociception and Binding with (+)-Thebaine” (Abstract), PubMed Database, National Library of Medicine, no date available.
Speigel et al., “Meptazinol a Novel Mu-1 Selective Opioid Analgesic” (Abstract), Biosis Database, no date available.
Elwood, “Sticky Business: Patterns of Procurement and Misuse of Prescription Cough Syrup in Houston”,Journal of Psychoactive Drugs, vol. 33, No. 2 (2001), pp. 121-133.
Crowell & Moring LLP
Gruenenthal GmbH
Henley III Raymond J.
LandOfFree
Use of weak opioids and mixed opioid agonists/antagonists... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of weak opioids and mixed opioid agonists/antagonists..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of weak opioids and mixed opioid agonists/antagonists... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581004